Questionnaires in clinical trials: guidelines for optimal design and administration
- PMID: 20064225
- PMCID: PMC2823735
- DOI: 10.1186/1745-6215-11-2
Questionnaires in clinical trials: guidelines for optimal design and administration
Abstract
A good questionnaire design for a clinical trial will minimise bias and maximise precision in the estimates of treatment effect within budget. Attempts to collect more data than will be analysed may risk reducing recruitment (reducing power) and increasing losses to follow-up (possibly introducing bias). The mode of administration can also impact on the cost, quality and completeness of data collected. There is good evidence for design features that improve data completeness but further research is required to evaluate strategies in clinical trials. Theory-based guidelines for style, appearance, and layout of self-administered questionnaires have been proposed but require evaluation.
References
-
- Armstrong BG. Optimizing power in allocating resources to exposure assessment in an epidemiologic study. Am J Epidemiol. 1996;144:192–197. - PubMed
-
- Hill AB. Observation and experiment. N Engl J Med. 1953;248:995–1001. - PubMed
-
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH harmonised tripartite guideline, statistical principles for clinical trials E9. http://www.ich.org/LOB/media/MEDIA485.pdf
-
- CIOMS. Management of safety information from clinical trials: report of CIOMS working group VI. Geneva, Switzerland: Council for International Organisations of Medical Sciences (CIOMS); 2005.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
